Log in to search using one of your social media accounts:

 

Computer program finds new uses for old drugs
(Case Western Reserve University) Researchers at the Case Comprehensive Cancer Center at Case Western Reserve University School of Medicine have developed a computer program to find new indications for old drugs. The computer program, called DrugPredict, matches existing data about FDA-approved drugs to diseases, and predicts potential drug efficacy. In a recent study published in Oncogene, the researchers successfully translated DrugPredict results into the laboratory, and showed common pain medications--like aspirin--can kill patient-derived epithelial ovarian cancer cells. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - November 16, 2017 Category: Cancer & Oncology Source Type: news

POISE-2: PCI Patients May Benefit From Perioperative Aspirin POISE-2: PCI Patients May Benefit From Perioperative Aspirin
A subgroup analysis of the POISE-2 trial suggests patients with a prior PCI may benefit from perioperative aspirin for subsequent noncardiac surgeries.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - November 15, 2017 Category: Consumer Health News Tags: Cardiology News Source Type: news

Is Low-Dose Aspirin Right for You After Surgery?
Source: HealthDay Related MedlinePlus Pages: Blood Clots, Surgery (Source: MedlinePlus Health News)
Source: MedlinePlus Health News - November 15, 2017 Category: Consumer Health News Source Type: news

Is Low-Dose Aspirin Right for You After Surgery?
Title: Is Low-Dose Aspirin Right for You After Surgery?Category: Health NewsCreated: 11/14/2017 12:00:00 AMLast Editorial Review: 11/15/2017 12:00:00 AM (Source: MedicineNet Heart General)
Source: MedicineNet Heart General - November 15, 2017 Category: Cardiology Source Type: news

Is Low-Dose Aspirin Right for You After Surgery?
TUESDAY, Nov. 14, 2017 -- Each year, millions of American heart patients go " under the knife " for various kinds of surgery. Often they're told to take a low-dose aspirin, to help lower their odds for a post-op blood clot. But does that practice... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - November 14, 2017 Category: General Medicine Source Type: news

Perioperative Aspirin Might Benefit Patients with Prior PCI
Perioperative aspirin seems beneficial for high-risk patients undergoing noncardiac surgery who've previously undergone percutaneous coronary intervention (PCI), according to a subanalysis from the POISE... (Source: Physician's First Watch current issue)
Source: Physician's First Watch current issue - November 14, 2017 Category: Primary Care Source Type: news

Aspirin can prevent heart attacks after noncardiac surgery in patients with prior PCI
(University of Alberta Faculty of Medicine& Dentistry) A Canadian-led study has found that perioperative aspirin can prevent heart-related complications after major noncardiac surgery in patients with previous percutaneous coronary intervention (PCI) such as an angioplasty or stent. The study found that for every 1,000 patients with PCI, giving them aspirin at the time of noncardiac surgery would prevent 59 heart attacks and cause eight major bleeding events. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - November 14, 2017 Category: International Medicine & Public Health Source Type: news

Low-Dose Aspirin Use and Cognitive Function in Older Age Low-Dose Aspirin Use and Cognitive Function in Older Age
Might low-dose aspirin, with its anti-inflammatory properties, have a favorable effect on cognition in the elderly?Journal of the American Geriatrics Society (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - November 13, 2017 Category: Consumer Health News Tags: Neurology & Neurosurgery Journal Article Source Type: news

DACAB: Ticagrelor Plus Aspirin Improves CABG Graft Patency DACAB: Ticagrelor Plus Aspirin Improves CABG Graft Patency
Results showed dual therapy with aspirin and ticagrelor resulted in improved patency of saphenous vein grafts vs either agent alone, but the data are unlikely to change practice yet, observers say.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - November 13, 2017 Category: Consumer Health News Tags: Cardiology News Source Type: news

Speed makes a difference when using clot-stabilising drug in severe bleeding
Immediate treatment with clot-stabilising drug can reduce risk of death due to blood loss by 70% Related items fromOnMedica Heavy menstrual bleeding Bleeding risk with long-term aspirin increases substantially with age Direct oral anticoagulants as safe as warfarin after VTE Include pregnant women in studies, urge researchers (Source: OnMedica Latest News)
Source: OnMedica Latest News - November 8, 2017 Category: UK Health Source Type: news

Aspirin May Improve Exercise Endurance in MS Aspirin May Improve Exercise Endurance in MS
A small pilot study suggests aspirin may be an'easy, economical'treatment to minimize overheating with exertion and allow patients with multiple sclerosis to get the benefits of exercise.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - November 7, 2017 Category: Consumer Health News Tags: Neurology & Neurosurgery News Source Type: news

Bayer submits application for marketing approval of rivaroxaban for patients with coronary or peripheral artery disease to European Medicines Agency (for specialized target groups only)
The rivaroxaban vascular dose, 2.5 mg twice daily plus aspirin 100 mg once daily, demonstrated a 24% reduction in the combined risk of stroke, cardiovascular death and heart attack / The application for marketing approval is based on the COMPASS study / If approved, the rivaroxaban vascular dose, 2.5 mg twice daily plus aspirin low dose once daily, will be the only non-vitamin K antagonist oral anticoagulant (NOAC) indicated for this patient population (Source: Bayer Company News)
Source: Bayer Company News - November 6, 2017 Category: Pharmaceuticals Source Type: news

Morning Rounds: Aspirin risks, effects of space travel on the brain
CBS News medical contributor Dr. David Agus joins "CBS This Morning: Saturday" to discuss new research about the risks of long-term aspirin use, a study about the potential effects of space travel on the human brain and why it might be a good idea to add more spicy food to your diet. (Source: Health News: CBSNews.com)
Source: Health News: CBSNews.com - November 4, 2017 Category: Consumer Health News Source Type: news

Aspirin: the tonic for good health
IF EVER a form of medication deserved the term “wonder drug” it’s aspirin. (Source: Daily Express - Health)
Source: Daily Express - Health - November 1, 2017 Category: Consumer Health News Source Type: news

PFA - 100 - Measured Aspirin Resistance Linked to CV Events
Strong correlation between aspirin resistance, CV events at 5 - year follow - up in aspirin - treated patients (Source: Pulmonary Medicine News - Doctors Lounge)
Source: Pulmonary Medicine News - Doctors Lounge - October 31, 2017 Category: Respiratory Medicine Tags: Cardiology, Family Medicine, Geriatrics, Gynecology, Internal Medicine, Neurology, Nursing, Pathology, Pharmacy, Pulmonology, Journal, Source Type: news

Long-Term Aspirin Use May Reduce Cancer Risk, Study Finds
A large-scale study of aspirin users found a link between taking aspirin long-term and significant risk reduction for multiple types of cancer. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - October 31, 2017 Category: Pharmaceuticals Authors: David DiSalvo, Contributor Source Type: news

Aspirin 'cuts risk of cancer by up to half'
A trial involving more than half a million people found long-term aspirin users cut their risk of liver and oesophageal cancer by almost half, while their odds of getting bowel cancer fell by a quarter. (Source: the Mail online | Health)
Source: the Mail online | Health - October 31, 2017 Category: Consumer Health News Source Type: news

Medical News Today: Aspirin slashes risk of gastrointestinal cancer
A large-scale study finds that regular, long-term use of aspirin may be able to prevent the development of different gastrointestinal cancers. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - October 31, 2017 Category: Consumer Health News Tags: Cancer / Oncology Source Type: news

Aspirin can HALVE risk of some deadly cancers, a study has found
AN ASPIRIN a day can halve the risk of developing some cancers, a major study suggests. (Source: Daily Express - Health)
Source: Daily Express - Health - October 31, 2017 Category: Consumer Health News Source Type: news

FDA Approves New 10 mg Dosing for XARELTO(R) (rivaroxaban) to Reduce the Continued Risk of Venous Thromboembolism (VTE)
XARELTO® is the only Factor Xa inhibitor to demonstrate superior efficacy in reducing the continued risk of recurrent VTE after initial treatment and with major bleeding rates similar to aspirin Phase 3 EINSTEIN CHOICE study shows XARELTO® 10 mg... Biopharmaceuticals, FDA Janssen Pharmaceuticals, XARELTO, rivaroxaban, Venous Thromboembolism (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - October 30, 2017 Category: Pharmaceuticals Source Type: news

Bayer receives FDA approval for Xarelto ® 10 mg once daily for the extended treatment of venous thromboembolism (for specialized target groups only)
Rivaroxaban (Xarelto ®) 10 mg once daily significantly reduces the risk of recurrent venous thromboembolism compared with aspirin 100 mg once daily following at least six months of standard anticoagulation therapy / FDA approval based on data from the EINSTEIN CHOICE study (Source: Bayer Company News)
Source: Bayer Company News - October 30, 2017 Category: Pharmaceuticals Source Type: news

Talwin Compound (Pentazocine and Aspirin) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - October 30, 2017 Category: Drugs & Pharmacology Source Type: news

Long-term aspirin use reduces the incidence of digestive cancers by up to 47 percent
(Spink Health) In a study involving over 600,000 people, those prescribed with aspirin showed a 47 percent reduction in liver and esophageal cancer incidence, a 38 percent reduction in gastric cancer incidence, a 34 percent reduction in pancreatic cancer incidence and a 24 percent reduction in colorectal cancer incidence. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - October 30, 2017 Category: Cancer & Oncology Source Type: news

Mumsnet users reveal their very unusual beauty hacks
A woman took to Mumsnet to aske for unusual beauty tips that really work, and was told to try glaucoma eye drops to thicken lashes, cider vinegar to rinse her hair and aspirin paste to kill spots. (Source: the Mail online | Health)
Source: the Mail online | Health - October 29, 2017 Category: Consumer Health News Source Type: news

Study claims aspirin cuts breast cancer risk by 47 percent in women with diabetes
(Natural News) The American Diabetes Association warns that at least 9.3 percent of the population has diabetes, with 1.4 million new diagnoses in the U.S. each year. This lethal disease is the seventh leading cause of death in the country, and is often an underlying cause listed on death certificates. Type 2 diabetes is the... (Source: NaturalNews.com)
Source: NaturalNews.com - October 29, 2017 Category: Consumer Health News Source Type: news

Aspirin for Prevention of Cardiovascular Disease Aspirin for Prevention of Cardiovascular Disease
This study examined aspirin use for the prevention of primary and secondary cardiovascular disease in a cohort of Mississippi adults. Are there sociodemographic disparities?Preventing Chronic Disease (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - October 25, 2017 Category: Consumer Health News Tags: Cardiology Journal Article Source Type: news

Aspirin may reduce risk for liver cancer in hepatitis B patients, study says
Daily aspirin may reduce the risk of liver cancer for people with hepatitis B infection, a new study suggests. (Source: Health News - UPI.com)
Source: Health News - UPI.com - October 20, 2017 Category: Consumer Health News Source Type: news

Medical News Today: Daily aspirin could ward off liver cancer
Taking aspirin every day could help to lower the risk of liver cancer for patients infected with hepatitis B, a new study suggests. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - October 20, 2017 Category: Consumer Health News Tags: Liver Disease / Hepatitis Source Type: news

Can Aspirin Stop Liver Cancer in Hep B Patients?
Study from Taiwan finds link between aspirin use and reduced cancer risk (Source: WebMD Health)
Source: WebMD Health - October 20, 2017 Category: Consumer Health News Source Type: news

Can Aspirin Stop Liver Cancer in Hepatitis B Patients?
FRIDAY, Oct. 20, 2017 -- Daily aspirin may reduce the risk of liver cancer for people with hepatitis B infection, a new study suggests. Hepatitis B virus attacks the liver and can cause cirrhosis and liver cancer. Previous research suggests daily... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - October 20, 2017 Category: General Medicine Source Type: news

Durlaza (Aspirin Capsules) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - October 20, 2017 Category: Drugs & Pharmacology Source Type: news

Can Aspirin Stop Liver Cancer in Hepatitis B Patients?
Title: Can Aspirin Stop Liver Cancer in Hepatitis B Patients?Category: Health NewsCreated: 10/20/2017 12:00:00 AMLast Editorial Review: 10/20/2017 12:00:00 AM (Source: MedicineNet Digestion General)
Source: MedicineNet Digestion General - October 20, 2017 Category: Nutrition Source Type: news

Aspirin Given After Colorectal Cancer Diagnosis Still Useful Aspirin Given After Colorectal Cancer Diagnosis Still Useful
Low-dose daily aspirin, thought to play a role in the prevention of colorectal cancer, might also improve survival if started after diagnosis, report researchers.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - October 19, 2017 Category: Consumer Health News Tags: Gastroenterology News Source Type: news

Yosprala (Aspirin and Omeprazole Tablets) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - October 18, 2017 Category: Drugs & Pharmacology Source Type: news

Aspirin habits unchanged by recommendations from U.S. doctors
(Reuters Health) - U.S. guidelines urging more adults who never had a heart attack or stroke to take a daily aspirin may not have convinced people to take these pills, a recent study suggests. (Source: Reuters: Health)
Source: Reuters: Health - October 13, 2017 Category: Consumer Health News Tags: healthNews Source Type: news

Injection releases aspirin over a month
Researchers from the Indian Institute of Science in  Bangalore have developed a jab that releases eight per cent of its aspirin in week one, 13 per cent in week two and 20 per cent in week four. (Source: the Mail online | Health)
Source: the Mail online | Health - October 12, 2017 Category: Consumer Health News Source Type: news

Aspirin vs. NSAIDs (Side Effect and Use Differences)
Title: Aspirin vs. NSAIDs (Side Effect and Use Differences)Category: MedicationsCreated: 10/10/2017 12:00:00 AMLast Editorial Review: 10/10/2017 12:00:00 AM (Source: MedicineNet Medications General)
Source: MedicineNet Medications General - October 10, 2017 Category: Drugs & Pharmacology Source Type: news

Synalgos DC (Aspirin, Caffeine, and Dihydrocodeine Bitartrate Capsules, USP) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - October 9, 2017 Category: Drugs & Pharmacology Source Type: news

Oct 6 Cardiology News Oct 6 Cardiology News
Stopping aspirin, TAVR durability, meditation, triathlon risk, and BP control in low-income patients are discussed by Dr Mandrola in this week's podcast.theheart.org on Medscape (Source: Medscape Cardiology Headlines)
Source: Medscape Cardiology Headlines - October 6, 2017 Category: Cardiology Tags: Cardiology News Source Type: news

Bayer says Phase III Xarelto study halted early
BERLIN (Reuters) - Bayer and partner Johnson& Johnson suffered a setback for blockbuster clot prevention drug Xarelto, with the German company saying a Phase III study had been halted early after the drug showed no efficacy improvements over low-dose aspirin. (Source: Reuters: Health)
Source: Reuters: Health - October 6, 2017 Category: Consumer Health News Tags: healthNews Source Type: news

You won ’t believe what happened this morning
When I got to the office this morning, several of my employees were in a state of near-panic… I couldn’t imagine what might have happened… and I was alarmed. Turns out, the coffee maker was on the fritz. Coffee is the “drug” of choice for many of the people on my staff. And they’re not alone… An astounding 80% of Americans use the caffeine in coffee to boost their energy. The buzz helps them wake up every morning and gets their day going. And older adults drink coffee more than anyone else. In fact, in a survey by the National Coffee Association, 20% of people over 64 said they ...
Source: Al Sears, MD Natural Remedies - October 5, 2017 Category: Complementary Medicine Authors: Al Sears Tags: Anti-Aging Source Type: news

African power plant relieves migraine
I treat a lot of different kinds of chronic pain at my clinic. The patients most desperate for relief are the migraine sufferers. If you get migraines, you know they can knock you out for days at a time. The World Health Organization says migraines are to blame for more lost years of healthy life than multiple sclerosis, epilepsy, ovarian cancer and tuberculosis combined.1 But mainstream medicine knows very little about the cause of migraines or how to treat them. Most doctors prescribe Imitrex. That’s a drug to help relieve headaches, pain, nausea, and sensitivity to light and sound.  But Imitrex can actually ...
Source: Al Sears, MD Natural Remedies - October 5, 2017 Category: Complementary Medicine Authors: Randall Hall Tags: Brain Health Men's Health Women's Health Source Type: news

Stopping Long-term Aspirin Linked to CV-Event Spike Stopping Long-term Aspirin Linked to CV-Event Spike
The elevated risk appeared shortly after patients stopped aspirin and did not appear to diminish over time, the investigators report.Medscape Medical News (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - October 4, 2017 Category: Consumer Health News Tags: Cardiology News Source Type: news

Michelle is moving ahead after experiencing a stroke
In fall of 2014, I was a senior, excited about finishing high school in New Hampshire and heading off to college. But I could never have guessed what the year would bring. I was an avid lacrosse player and competing in my fifth game of a tournament when I started to notice I was having trouble seeing out of my left eye. Soon, my hand felt weird and I couldn’t grip the stick properly. As I sat on the sidelines, onlookers recommended I be taken to a local hospital. Recovering from stroke I can’t remember a lot of what happened next, but I know that the emergency doctors believed I had a stroke. They sent me to th...
Source: Thrive, Children's Hospital Boston - October 2, 2017 Category: Pediatrics Authors: Michelle Ostaudelafont Tags: Diseases & Conditions Our Patients’ Stories Dr. Cameron Trenor Dr. Laura Lehman pediatric stroke Stroke and Cerebrovascular Center Source Type: news

Twice-Daily Aspirin Better to Prevent CVD in Diabetes? Twice-Daily Aspirin Better to Prevent CVD in Diabetes?
An early study suggests that more frequent aspirin dosing might up antiplatelet protection in patients with type 2 diabetes, but these lab findings require verification in clinical studies.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - October 2, 2017 Category: Consumer Health News Tags: Diabetes & Endocrinology News Source Type: news

Twice-Daily Aspirin for CVD in Diabetes
Twice-Daily Aspirin Better to Prevent CVD in Diabetes? (Source: eMedicineHealth.com)
Source: eMedicineHealth.com - October 2, 2017 Category: General Medicine Source Type: news

PodMed: A Medical News Roundup From Johns Hopkins (with audio)
(MedPage Today) -- This week's topics include aspirin discontinuation risks, HIV in those 50 and older, big data and chronic lung disease, and genetic testing and warfarin use (Source: MedPage Today Cardiovascular)
Source: MedPage Today Cardiovascular - September 30, 2017 Category: Cardiology Source Type: news

Stopping aspirin therapy may raise heart attack, stroke risk
(Reuters Health) - Stopping low-dose aspirin therapy without good reason raises the likelihood of heart attack or stroke by nearly 40 percent, a large Swedish study suggests. (Source: Reuters: Health)
Source: Reuters: Health - September 29, 2017 Category: Consumer Health News Tags: healthNews Source Type: news

Tool Predicts Added Disease-Free Life With Drug Changes in Diabetes Tool Predicts Added Disease-Free Life With Drug Changes in Diabetes
A newly developed decision support tool can help guide treatment with statins, aspirin, or antihypertensives in patients with type 2 diabetes.Medscape Medical News (Source: Medscape Diabetes Headlines)
Source: Medscape Diabetes Headlines - September 27, 2017 Category: Endocrinology Tags: Diabetes & Endocrinology News Source Type: news

Pensioners who stop aspirin up heart attack risk by 37%
Quitting a daily dose of the pill raises the risk of cardiovascular events by 37%, a study by Uppsala University in Sweden found. Sudden withdrawal can cause blood clots in a 'rebound effect'. (Source: the Mail online | Health)
Source: the Mail online | Health - September 26, 2017 Category: Consumer Health News Source Type: news